About: Cambium Bio Limited, a clinical-stage regenerative medicine company, focuses on developing biologics for ophthalmology and tissue repair applications. The company provides Elate Ocular for the treatment of dry eye disease. The company also develops Progenza, a stem cell platform for knee osteoarthritis and other tissue repair indications; and Sygenus, for wound healing indications. Cambium Bio Limited is headquartered in Bella Vista, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.54 (-0.92%)
CMB ASX Cambium Bio Ltd
Cambium Bio Ltd share price
CMB price activity
Último preço
$ 0,540
Variação (24h)
-0,01 AUD (-0,92%)
Volume
64
Volume (média 4 sem.)
-
Abertura
$ 0,54
Variação do dia
$ 0,54 - $ 0,54
Fechamento anterior
$ 0,55
Último negócio
04 Oct, 11:00 pm GMT+0
Atrasado
04 Oct, 11:00 pm GMT+0
CMB price performance
Atrasado
04 Oct, 11:00 pm GMT+0
quote.marketSignals